Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1

References

• Brew B J, Rosenblum M, Cronin M, Price R W. AIDS dementia complex and HIV-1 brain infection: clinical-virologic correlations. Ann Neurol 1995; 38: 563–570
   PubMed Web of Science ®Google Scholar
• Bukrinsky M I, Nottet H S, Schmidtmayerova H, Dubrovsky L, Flanagan C R, Mullins M E, Lipton S A, Gendelman H E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. Implications for HIV-1-associated neurological diseases. J Biol Chem 1997; 272: 22385–22388
   PubMed Web of Science ®Google Scholar
• Chin K-C, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 2001; 98: 15125–15130
   PubMed Web of Science ®Google Scholar
• Choe W, Volsky D J, Potash M J. Induction of rapid and extensive β -chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J Virol 2001; 75: 10738–10745
   Google Scholar
• Cicala C, Arthos J, Selig S M, Dennis G, Jr., Hosack D A, Van Ryk D, Spangler M L, Steenbeke T D, Khazanie P, Gupta N, Yang J, Daucher M, Lempicki R A, Fauci A S. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A 2002; 99: 9380–9385
   PubMed Web of Science ®Google Scholar
• D'Aversa T G, Yu K OA, Berman J W. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J NeuroVirol 2004; 10: 86–97
   Google Scholar
• Fantuzzi L, Canini I, Belardelli F, Gessani S. HIV-1 gp120 stimulates the production of β -chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J Immunol 2001; 166: 5381–5387
   PubMedGoogle Scholar
• Gartner S, Markovits P, Markovitz D M, Kaplan M H, Gallo R C, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986; 233: 215–219
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Orenstein J M, Martin M A, Ferrua C, Mitra R, Phipps T, Wahl L A, Lane H C, Fauci A S, Burke D S, Skillman D, Meltzer M S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor-1 treated monocytes. J Exp Med 1988; 167: 1428–1441
   PubMed Web of Science ®Google Scholar
• Gendelman H E, Zheng J, Coulter C L, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Jr, Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis 1998; 178: 1000–1007
   PubMed Web of Science ®Google Scholar
• Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E, Carhart L, Shafer L, Gendelman H E. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 1998; 72: 3340–3350
   Google Scholar
• Giulian D, Wendt E, Vaca K, Noonan C A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A 1993; 90: 2769–2773
   PubMedGoogle Scholar
• Glass J D, Fedor H, Wesselingh S L, McArthur J C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38: 755–762
   PubMed Web of Science ®Google Scholar
• González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5: 69–81
   PubMed Web of Science ®Google Scholar
• Gorry P R, Bristol G, Zack J A, Ritola K, Swanstrom R, Birch C J, Bell J E, Bannert N. K. C., Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky S M, Gabuzda D. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001; 75: 10073–10089
   PubMed Web of Science ®Google Scholar
• Gottlieb M S, Schroff R, Schanker H M, Weisman J D, Fan P T, Wolf R A, Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425–1431
   PubMed Web of Science ®Google Scholar
• Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772–777
   PubMed Web of Science ®Google Scholar
• Horuk R, Hesselgesser J, Zhou Y, Faulds D, Halks-Miller M, Harvey S, Taub D, Samson M, Parmentier M, Rucker J, Doranz B J, Doms R W. The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J Biol Chem 1998; 273: 386–391
   PubMed Web of Science ®Google Scholar
• Kim M-O, Si Q, Zhou J N, Pestell R G, Brosnan C F, Locker J, Lee S C. Interferon-β activates multiple signaling cascades in primary human microglia. J Neurochem 2002; 81: 1361–1371
   PubMed Web of Science ®Google Scholar
• Kohler J J, Tuttle D L, Coberley C R, Sleasman J W, Goodenow M M. Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages. J Leukoc Biol 2003; 73: 407–416
   Google Scholar
• Li Y, Kappes J C, Conway J A, Price R W, Shaw G M, Hahn B H. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured brain tissue: identification of replication-competent and -defective viral genomes. J Virol 1991; 65: 3973–3985
   PubMed Web of Science ®Google Scholar
• Liu Q-H, Williams D A, McManus C, Baribaud F, Doms R W, Schols D, De Clercq E, Kotlikoff M I, Collman R G, Freedman B D. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc Natl Acad Sci U S A 2000; 97: 4832–4837
   Google Scholar
• Mankowski J L, Queen S E, Clements J E, Zink M C. Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol 2004; 157: 66–70
   Google Scholar
• McArthur J C, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 2003; 9: 205–221
   PubMed Web of Science ®Google Scholar
• Meylan P R, Guatelli J C, Munis J R, Richman D D, Kornbluth R S. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 1993; 193: 138–148
   Google Scholar
• O'Brien S J, Moore J P. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 2000; 177: 99–111
   PubMed Web of Science ®Google Scholar
• Peters P J, Bhattacharya J, Hibbitts S, Dittmar M T, Simmons G, Bell J, Simmonds P, Clapham P R. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 2004; 78: 6915–6926
   Google Scholar
• Power C, McArthur J C, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson R T, Chesebro B. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998; 72: 9045–9053
   PubMed Web of Science ®Google Scholar
• Roberts E S, Burudi E ME, Flynn C, Madden L J, Roinick K L, Watry D D, Zandonatti M A, Taffe M A, Fox H S. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol 2004; 157: 81–92
   PubMed Web of Science ®Google Scholar
• Roberts E S, Zandonatti M A, Watry D D, Madden L J, Henriksen S J, Taffe M A, Fox H S. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 2003; 162: 2041–2057
   PubMed Web of Science ®Google Scholar
• Roberts N A, Martin J A, Kinchington D, Broadhurst A V, Craig J C, Duncan I B, Galpin S A, Handa B K, Kay J, Kröhn A, Lambert R W, Merrett J H, Mills J S, Parkes K EB, Redshaw S, Ritchie A J, Taylor D L, Thomas G J, Machin P J. Rational design of peptide-based HIV proteinase inhibitors. Science 1990; 248: 358–361
   PubMed Web of Science ®Google Scholar
• Selvan R S, Zhou L J, Krangel M S. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 1997; 27: 687–694
   PubMedGoogle Scholar
• Smit T K, Wang B, Ng T, Osborne R, Brew B, Saksena N K. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. Virology 2001; 279: 509–526
   PubMed Web of Science ®Google Scholar
• Sui Z, Sniderman L F, Fan S, Kazmierczak K, Reisenger E, Kovacs A, Potash M J, Dewhurst S, Gelbard H, Maggirwar S. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3 beta to antagonize nuclear factor kappaB survival pathway in neurons. Eur J Neurosci 2006; 23: 2623–2634
   PubMedGoogle Scholar
• Swingler S, Mann A, Jacque J, Brichacek B, Sasseville V G, Williams K, Lackner A A, Janoff E N, Wang R, Fisher D, Stevenson M. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999; 9: 997–103
   Google Scholar
• Vázquez N, Greenwell-Wild T, Marinos N J, Swaim W D, Nares S, Ott D E, Schubert U, Henklein P, Orenstein J M, Sporn M B, Wahl S M. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol 2005; 79: 4479–4491
   PubMed Web of Science ®Google Scholar
• Verma S, Ziegler K, Ananthula P, Co J KG, Frisque R J, Yanagihara R, Nerurkar V R. JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology 2006; 345: 457–467
   Google Scholar
• Wahl L M, Corcoran M L, Pyle S W, Arthur L O, Harel-Bellan A, Farrar W L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A 1989; 86: 621–625
   PubMed Web of Science ®Google Scholar
• Zhang K, Rana F, Silva C, Ethier J, Wehrly K, Chesebro B, Power C. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol 2003; 77: 6899–6912
   PubMed Web of Science ®Google Scholar
• Zheng J, Ghoparde A, Niemann D, Cotter R L, Thylin M R, Epstein L, Swartz J M, Shepard R B, Liu X, Nukuna A, Gendelman H E. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia. J Virol 1999; 73: 8256–8267
   PubMed Web of Science ®Google Scholar
• Zhu Y, Jones G, Tsutsui S, Opii W, Liu S, Silva C, Butterfield D A, Power C. Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase. J Immunol 2005; 175: 1118–1126
   PubMedGoogle Scholar